Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oak Crest Institute of Science
Monrovia, California, United Statesoak-crest.org ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Oak Crest Institute of Science has developed an HIV prevention technology using a vaginal ring platform for drug delivery that entered Phase 1 clinical trials in 2020, supported by multiple rounds of NIH funding.[1]
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small moleculeBiologicVaccine
- Industry
- Academic Hospital/University/Research
02
Partnerships
National Institutes of Health (NIH) grant-funded collaborations on HIV prevention and drug-delivery technologies[1]National Science Foundation (NSF) grant support for research programs[1]City of Monrovia and Newton World Enterprises via the Monrovia–Oak Crest Science and Technology Incubator Program (MOST-IP)[7]
Beyond the preview
Go deeper on Oak Crest Institute of Science.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oak Crest Institute of Science.